IUPAC and Gedeon Richter, Plc. are pleased to announce the 2024 IUPAC-Richter Prize in Medicinal Chemistry. The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery. It is endowed with USD 10’000.
The 2024 IUPAC-Richter Prize will be presented during the XXVIII EFMC International Symposium on Medicinal Chemistry (1-5 September 2024) in Rome (Italy) and the recipient will also give a lecture at the 38th ACS National Medicinal Chemistry Symposium (23-26 June 2024) in Seatle (USA).
Applications are by nomination, with only one person needing to serve in that capacity, although a total of five individuals should additionally be listed as references. The nomination package must be submitted via this form and should contain:
- a complete resume,
- a professional biography of not more than two pages, and
- a one-page summary of what the individual considers to be their activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry.
Nomination deadline is December 15, 2023.
The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Drug Discovery and Development.
For further information please contact Prof. Janos Fischer, Chair of the Jury and member of the IUPAC Sub-committee on Drug Discovery and Development, by email at
More information on https://iupac.org/2024-iupac-richter-prize-call-for-nominations/
David Spichiger, SCS
13.10.2023